Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

HIV can cause various nail and hair disorders, important for early diagnosis and treatment.

Nail disorders are often related to jobs like housework and manual labor, with cosmetic issues being the main concern, and are commonly caused by skin diseases like psoriasis.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

A new benign nail tumor called onychoblastoma was identified.

A rare finger tumor was imaged, showing a unique pattern not seen before.

An 11-year-old girl with severe hair loss was successfully treated with a new combination therapy.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Older adults commonly experience hair loss and nail disorders due to aging and health changes, affecting their quality of life.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Most injecting drug users in the study had hepatitis C and skin problems, which moderately affected their quality of life.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

A nutrition program improved a young woman's concussion symptoms.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

An 86-year-old man had a rare tongue melanoma but refused treatment, showing the need for early cancer detection and treatment.

A rare nail bed cancer was successfully treated with no recurrence after 4 years.

Apoptosis in hair follicles spreads through cell death signals, with stem cells slowing the process.

Melanocytic matricoma can look like skin cancer but is usually harmless; surgery and follow-up are advised.

The man died from lung cancer, not the rare nail tumor.

Onychomatricome is a benign nail tumor with specific dermoscopic features that help distinguish it from cancer.

A rare pigmented skin tumor called melanotrichoblastoma was diagnosed in a 51-year-old woman.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Podiatrists need more training to detect foot melanoma early.

A rare benign skin growth called melanocytic matricoma was identified in a 69-year-old man.

Hair repigmentation can indicate malignancy and should be investigated.

Non-melanoma skin cancer in darker-skinned people can be misdiagnosed, so doctors need to be more aware to diagnose it correctly and early.

Scalp melanomas are more dangerous and likely to recur or cause death than other head and neck melanomas.

Scalp melanomas are more dangerous and often missed, needing earlier detection.